✦ LIBER ✦

A novel glycogen synthase kinase-3 inhibitor 2-methyl-5-(3-{4-[(s)-methylsulfinyl]phenyl}-1-benzofuran-5-yl)-1,3,4-oxadiazole (mmbo) decreased tau phosphorylation and ameliorated cognitive deficits in a transgenic model of Alzheimer's disease

✍ Scribed by Onishi, Tomohiro; Iwashita, Hiroki; Uno, Yumiko; Kunitomo, Jun; Saitoh, Morihisa; Kimura, Eiji; Fujita, Hisashi; Uchiyama, Noriko; Kori, Masakuni; Takizawa, Masayuki

Book ID: 123097115
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 54 KB
Volume: 7
Category: Article
ISSN: 1552-5260
DOI: 10.1016/j.jalz.2011.05.1400

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A novel glycogen synthase kinase-3 inhib

A novel glycogen synthase kinase-3 inhibitor 2-methyl-5-(3-{4-[(S )-methylsulfinyl]phenyl}-1-benzofuran-5-yl)-1,3,4-oxadiazole decreases tau phosphorylation and ameliorates cognitive deficits in a transgenic model of Alzheimer’s disease

✍ Tomohiro Onishi; Hiroki Iwashita; Yumiko Uno; Jun Kunitomo; Morihisa Saitoh; Eij 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 731 KB

Discovery of (S)-2-((S)-2-(3,5-Difluorop

Discovery of (S)-2-((S)-2-(3,5-Difluorophenyl)-2-hydroxyacetamido)-N-( (S,Z)-3-methyl-4-oxo-4,5-dihydro-3H-benzo[d] [1,2]diazepin-5-yl)propanamide (BMS-433796): A γ-Secretase Inhibitor with Aβ Lowering Activity in a Transgenic Mouse Model of Alzheimer′s Disease.

✍ C. V. C. Prasad; et al. et al. 📂 Article 📅 2007 🏛 John Wiley and Sons ⚖ 21 KB 👁 1 views